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A 22-year-old female patient received penetrating keratoplasty (PK) of her right eye for ocular rosacea
complicated with corneal perforation. Intraocular pressure (IOP) ﬂuctuated and could not be well
controlled by full antiglaucomatous agents after surgery. Therefore transscleral diode laser cyclo-
photocoagulation (TSCPC) was performed for the intractable glaucoma one year after PK. Unfortunately,
acute cataract formation was noted 50 days after the laser treatment. Pigmented keratic precipitates
(KPs) developed and IOP rose subsequently. Cataract extraction with intraocular lens implantation
combined with trabeculectomy was performed 3 months later. Polymerase chain reaction (PCR) tests of
the aqueous humor to detect cytomegalovirus (CMV) and herpes simplex virus (HSV) were negative.
However, HSV type I DNA was detected in the lenticular material and excised trabecular tissue. Trabe-
culitis caused by herpetic infection could be the reason of ﬂuctuated and intractable IOP elevation. The
virus hidden in the intraocular tissue could be reactivated by TSCPC and result in cataract formation.
Therefore, performing TSCPC in a phakic eye with atypical IOP presentation should be undertaken with
caution.
Copyright  2011, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Glaucoma is one of the most serious complications of pene-
trating keratoplasty (PK) because of its high incidence, morbidity
and difﬁculty of diagnosis and treatment. Transscleral diode laser
cyclophotocoagulation (TSCPC) is a well-established, effective
method of cyclodestruction in glaucoma therapy, especially for
post-PK glaucoma.1 Early complications, such as pain, iritis and
conjunctival burns are common and transient, while severe
complications, such as phthisis and bulbus hypotonia are rare.2
However, cataract after TSCPC has not yet been reported. Here,
we report on a rapid cataract formation which might be due to
reactivation of herpes simplex virus type 1 (HSV-1) in the eye after
TSCPC for an intractable glaucoma after PK. This case was con-
ducted according to the Tenets of Helsinki, was approved by the
hospital Institutional Review Board (IRB), and the patient provided
written, informed consent to participate.ogy, Zhongxing Branch, Taipei
t, Taipei City 10341, Taiwan.
e Ophthalmologic Society of Taiwa2. Case presentation
A 22-year-old female received PK in her right eye for ocular
rosacea with leucoma adherence in December 2007. Intraocular
pressure (IOP) was elevated to 40 mmHg on Day 8 after surgery.
Steroid-induced glaucoma was suspected. Hence, 0.1% dexameth-
asone eye drop every 2 hours was changed to 0.1% ﬂuorometholone
acetate (Flarex, Alcon, Fort Worth, TX, USA) four times a day and
combined with 2% Carteolol (Arteoptic, Otsuka, Japan) twice a day
to treat her glaucoma. IOP decreased to 16 mmHg within one
week. Preoperative best corrected visual acuity (BCVA) of 10/200
improved to 20/25 2months after PK. Topical steroidwas decreased
to once a day 6months after PK, and discontinued at one year. Clear
graft with silent anterior chamber and a posterior synechiae on
pupil margin in the 5 to 6 o’clock position were noted in June 2008
(Fig. 1). However, the patient’s IOP ﬂuctuated between 12 and
40 mmHg during the follow-up period and could not be controlled
with full antiglaucomatous agents starting in November 2008. The
angle was generally wide except there are few peripheral anterior
synechiae with moderate pigmentation on trabecular meshwork
around the 6 o’clock position. Initially, the cup to disc ratio
was about 20e30% of both eyes immediately after penetratingn. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Clear graft with silent anterior chamber and a posterior synechiae on the pupil
margin in the 5 to 6 o’clock position 6 months after penetrating keratoplasty.
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of glaucoma. Therefore, a TSCPC (810 nm diode laser, power:
1500 mW, duration: 2 seconds, 19 applications over inferior 180)
was performed on February 20, 2009. About 50 days after TSCPC,
the patient complained of rapid decline of right eye vision for 2
weeks. Slit lamp examination disclosed a totally opaciﬁed lens
(Fig. 2) with a mild anterior chamber reaction. IOP of 14.6 mmHg
rose to 30þ mmHg during subsequent visits. A few pigmented
keratic precipitates (KPs) developed on both recipient and donor
endothelia. Rejection with possible viral keratouveitis was sus-
pected and the aqueous humor was aspirated for polymerase chain
reaction (PCR) test to detect herpes simplex virus (HSV) types I and
II and cytomegalovirus (CMV) DNA. For the nested PCR assay, we
used an initial activation of 94C for 1 minute, followed by 35 cycles
at 94C for 30 seconds, 57C for 30 seconds and 72C for 40 seconds,
with a ﬁnal reaction at 72C for 1 minute. Two microliters of the
ﬁrst ampliﬁed products were used for a second ampliﬁcation as the
same protocol. All results were negative. The corneal button excised
from PK was also negative of these viral DNAs. The serum IgG titer
of HSV-1 was 159.1 (þ). Reviewing her past history, we found no
major systemic diseases in the patient except for rosacea. AfterFig. 2. Totally opaciﬁed lens 2 months after transscleral diode laser cyclo-
photocoagulation. The pupil was dilated for fundus examination.hourly topical 0.1% ﬂuorometholone acetate instillation, the intra-
ocular inﬂammation was gradually alleviated but the IOP was still
above 25 mmHg under full medication. Because the visionwas only
counting ﬁngers, a cataract extraction with intraocular lens
implantation combined with a trabeculectomy was performed on
May 29, 2009. Surprisingly, PCR showed a positive result of HSV-1
in the aspirated lenticular material and the excised trabecular
tissue (Fig. 3), but not in the aqueous humor. Acyclovir 400 mg
twice a day was subsequently started and tapered gradually for 8
months. One month after the operation, BCVA improved to 20/30.
The number of pigmented KPs decreased, and IOP remained around
10mmHgwithout any anti-glaucomatous agents during one year of
follow-up.
3. Discussion
TSCPC is a well-established and effective method of cyclo-
destruction for glaucoma after PK.1 Most common complications,
including anterior chamber reaction, IOP spikes and conjunctival
burns, are mild and transient and do not inﬂuence the success of
the glaucoma treatment.2 Hardman et al3 observed cataract
development after TSCPC in canines. They use higher total laser
energies delivered to the eye than has been previously reported. It
is possible that an increased level of uveitis occurred after diode
laser TSCPC using a higher energy protocol, and the uveitis resulted
in cataract formation. Lens metabolism may be altered by the
change in aqueous humor composition after TSCPC. Cook et al4
suggest that the lens opacities seen may be in part a sequela to
the IOP elevation and/or its associated inﬂammation, rather than
a direct laser effect. In our case, the total laser energy was within
recommended ranges. This unusual complication was noted in theFig. 3. Polymerase chain reaction result of herpes simplex virus 1 analysis.
M ¼ molecular marker; N ¼ negative control; P ¼ positive control; S ¼ sample.
H.-C. Chung et al. / Taiwan Journal of Ophthalmology 1 (2011) 25e27 27right eye 50 days after TSCPC. Accordingly, we strongly suspect this
complication to be related to the laser surgery because cataracts
developed shortly after this treatment.
Herpes simplex is a common latent infection in humans which
spreads from sites of initial infection on skin or mucosal surfaces to
neuronal cell bodies, forming a long-term relationship with their
host.5 Reactivation of latent HSV could result in such ocular
complications as blepharitis, conjunctivitis, keratitis, iridocyclitis
and retinitis. Herpes virus infection has been also known to cause
cataract formation. In 1996, Bartz-Schmidt et al6 reported a case of
a 15-year-old female with recurrent herpes keratits, hypotonic
iridocyclitis and acute cataract formation, which diagnosis was
supported by aqueous humor immunological analysis. Biswas et al7
presented the case of a 23-year-old male with acute retinal necrosis
syndrome with complicated cataract in which HSV-1 was isolated
from the vitreous humor and lens material. Therese et al8 also re-
ported a case of a 33-year-old male presenting with HSV-induced
a posterior subcapsular cataract one year after an episode of
acute retinal necrosis syndrome. The diagnosis of HSV infectionwas
based on detection of HSV DNA in aqueous humor by PCR. Mitchell
andMartin9 used amousemodel to generate cataracts after corneal
inoculation with HSV type 1 strain F. They found lens lesions
appeared to be induced directly by viral replicationwithin the lens.
Raghu et al10 presented four cases of congenital cataract associated
with HSV-1 infection. In their report, three specimens from four
lens aspirates collected at the time of cataract surgery demon-
strated the existence of HSV-1 in tube culture, and all four lens
aspirates were positive for HSV-1 DNA by PCR.
We did not have a result for viral culture but the PCR result did
show the existence of HSV-1 in lens aspirates. Although, our patient
developed a cataract shortly after TSCPC, we would like to believe
that the rapid cataract formation was virus-related. We reason that
TSCPC caused a reactivation of HSV-1, which then replicated in the
lens and resulted in cataract formation.
Glaucoma after PK can occur as a result of angle compression,
inﬂammation, progressive synechial closure, pupillary block or
prolonged use of steroids. HSV-1 has also been implicated as an
important cause of secondary glaucoma.11 In our case, the angle of
the right eye was generally wide, and no chronic inﬂammation of
the anterior segment was noted. The HSV-1 DNA was detected in
excised trabecular tissue indicating that HSV-1 might have beeninvolved in the patient’s intractable glaucoma. Furthermore, the
clinical response to anti-viral agents was promising to further
support the associationwith HSV-1 infection in our case. Therefore,
these pictures supported the association of HSV-1 with the
formation of cataract and other clinical appearances.
In conclusion, a latent virus infection, such as HSV-1 in the
intraocular tissue could be reactivated by either surgery or steroid
usage, resulting in virus replication in the trabecular meshwork and
leading to a subsequent refractory glaucomawhich may be difﬁcult
to control with conventional anti-glaucomatous treatment. TSCPC
could also induce reactivation of a latent HSV-1 in the lens and
result in cataract formation. Therefore, we strongly suggest exer-
cising cautionwhen performing TSCPC in a phakic eyewith atypical
IOP presentation to avoid these complications.References
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